|
| Exchange Disseminated Time 29/03/2016 15:13:25 | | IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Independent Directors of the Company at its meeting held on March 29, 2016, inter alia, reviewed the performance of Non-Independent Directors and the Board as a whole; reviewed the performance of the Chairman of the Company and assessed the quality, quantity and timeliness of flow of information between the Company management and the Board in line with the requirement of regulation 25 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable provisions of Schedule IV of the Companies Act, 2013. |
|
|